KAYLA POPE: Open Payments
NPI 1134969678 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 133 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $930 · 2025 $2,753
Food & beverage: $2,753
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $348 |
| ABBVIE INC. | 18 | $299 |
| Lundbeck LLC | 11 | $268 |
| Neurocrine BioSciences, Inc. | 8 | $255 |
| Vanda Pharmaceuticals Inc. | 9 | $239 |
| Alkermes, Inc. | 11 | $191 |
| Axsome Therapeutics, Inc. | 8 | $166 |
| Janssen Pharmaceuticals, Inc | 5 | $145 |
| Corium, LLC | 5 | $121 |
| Collegium Pharmaceutical, Inc. | 7 | $114 |
Products named: REXULTI, CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, Auvelity, FANAPT, Azstarys.
Industry payments across FL — which companies pay providers there.
